NO921086L - Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner - Google Patents

Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner

Info

Publication number
NO921086L
NO921086L NO92921086A NO921086A NO921086L NO 921086 L NO921086 L NO 921086L NO 92921086 A NO92921086 A NO 92921086A NO 921086 A NO921086 A NO 921086A NO 921086 L NO921086 L NO 921086L
Authority
NO
Norway
Prior art keywords
trifluormytyluridines
didesoxy
substituted
procedure
preparation
Prior art date
Application number
NO92921086A
Other languages
English (en)
Norwegian (no)
Other versions
NO921086D0 (no
Inventor
Dieter Haebich
Rainer Neumann
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO921086D0 publication Critical patent/NO921086D0/no
Publication of NO921086L publication Critical patent/NO921086L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO92921086A 1991-04-05 1992-03-19 Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner NO921086L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4110977A DE4110977A1 (de) 1991-04-05 1991-04-05 Substituierte 2',3'-didesoxy-5-trifluormethyluridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln

Publications (2)

Publication Number Publication Date
NO921086D0 NO921086D0 (no) 1992-03-19
NO921086L true NO921086L (no) 1992-10-06

Family

ID=6428857

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92921086A NO921086L (no) 1991-04-05 1992-03-19 Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner

Country Status (15)

Country Link
EP (1) EP0507188A1 (fr)
JP (1) JPH05148261A (fr)
KR (1) KR920019813A (fr)
CN (1) CN1065462A (fr)
AU (1) AU640860B2 (fr)
CA (1) CA2064916A1 (fr)
CS (1) CS92092A3 (fr)
DE (1) DE4110977A1 (fr)
FI (1) FI921456A (fr)
HU (1) HUT60748A (fr)
IE (1) IE921083A1 (fr)
IL (1) IL101482A0 (fr)
NO (1) NO921086L (fr)
NZ (1) NZ242205A (fr)
TW (1) TW205043B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1050846C (zh) * 1995-08-03 2000-03-29 中国医学科学院医药生物技术研究所 一种抗肿瘤抗生素云南霉素及其制备方法
EP1387850A2 (fr) 2001-05-18 2004-02-11 Rakesh Kumar Nucleosides antiviraux
CN100334100C (zh) * 2004-01-17 2007-08-29 杭州富邦生物制药有限公司 5-三氟甲基-2’-脱氧尿苷的合成方法
JP4603274B2 (ja) * 2004-02-24 2010-12-22 三井化学株式会社 2’−デオキシ−5−トリフルオロメチルウリジンの製造方法
WO2009119785A1 (fr) * 2008-03-28 2009-10-01 浜理薬品工業株式会社 Procédé de purification d'un composé d'éthynylthymidine
WO2009125841A1 (fr) * 2008-04-10 2009-10-15 浜理薬品工業株式会社 Procédé de production d'éthynylthymidine utilisant la 5-méthyluridine en tant que matériau brut de départ

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048877A1 (de) * 1980-12-23 1982-07-08 Kailash Kumar Prof. Dr. 2359 Lentföhrden Gauri Pyrimidinnucleosid-phosphonate, verfahren zur herstellung und sie enthaltende mittel
DK224286A (da) * 1985-05-15 1986-11-16 Wellcome Found 2',3'-dideoxy-nucleosider
ATE190064T1 (de) * 1985-09-17 2000-03-15 Wellcome Found Kombination therapeutische nukleoside mit weiteren therapeutisch wirksamen komponenten.
CA1327000C (fr) * 1987-08-07 1994-02-15 David L.J. Tyrrell Therapie antivirale pour l'hepatite b
SE8704298D0 (sv) * 1987-11-03 1987-11-03 Astra Ab Compounds for use in therapy
US4900828A (en) * 1988-05-12 1990-02-13 Hoffmann-Laroche Inc. Intermediate compounds and an improved procedure for the synthesis of 2',3'-dideoxycytidine
SE8802173D0 (sv) * 1988-06-10 1988-06-10 Astra Ab Pyrimidine derivatives
GB8823320D0 (en) * 1988-10-05 1988-11-09 Nycomed As Chemical compounds
AU5659990A (en) * 1989-05-15 1990-12-18 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Method of treatment of hepatitis
IE902574A1 (en) * 1989-07-17 1991-02-27 Univ Birmingham Antiviral pyrimidine nucleosides

Also Published As

Publication number Publication date
CA2064916A1 (fr) 1992-10-06
NZ242205A (en) 1993-04-28
EP0507188A1 (fr) 1992-10-07
IE921083A1 (en) 1992-10-07
DE4110977A1 (de) 1992-10-08
CS92092A3 (en) 1992-12-16
NO921086D0 (no) 1992-03-19
TW205043B (fr) 1993-05-01
KR920019813A (ko) 1992-11-20
HUT60748A (en) 1992-10-28
CN1065462A (zh) 1992-10-21
AU1219092A (en) 1992-10-08
FI921456A0 (fi) 1992-04-02
IL101482A0 (en) 1992-12-30
AU640860B2 (en) 1993-09-02
FI921456A (fi) 1992-10-06
HU9201117D0 (en) 1992-06-29
JPH05148261A (ja) 1993-06-15

Similar Documents

Publication Publication Date Title
NO921589D0 (no) Fremgangsmaate for fremstilling av lavere polyoler og blandinger derav
NO894539D0 (no) Fremgangsmaate for fremstilling av nye 2'-halomethyliden-,2'-ethenyliden- og 2'-ethynylcytidin-, uriden og guanosinderivater.
NO911432L (no) Fremgangsmaate for fremstilling av 3,5-disubstituerte 2-isoksazoliner og isoksazoler.
HK19496A (en) Use of 1,2,2,3,3-penta-fluoropropane
NO922426L (no) Forbindelser med reninhemmende egenskaper, fremgangsmaate for fremstilling av disse og deres anvendelse
NO304384B1 (no) Al-Sr-Si-B-forlegering, fremgangsmÕte for dens fremstilling og anvendelse av forlegeringen
NO940027L (no) Fremgangsmaate for fremstilling av derivater av B-fenylisorerin og derivatenes anvendelse
NO893826L (no) Fremgangsmaate for fremstilling av 2'-halomethyliden, 2'-ethenyliden og 2'-ethenyladenosinderivater.
NO912486D0 (no) Fremgangsmaate for fremstilling av katalysator-nett og anvendelse av dette.
NO900643L (no) Fremgangsmaate for fremstilling og anvendelse av 2,3,23-trihydroksi-urs-12-ener og deres derivater.
NO920049D0 (no) Fremgangsmaate for fremstilling av 3-eksometylencefamsulfoksydestere
NO932129D0 (no) Fremgangsmaate for fremstilling og anvendelse av nye tienotiazinderivater
NO921086L (no) Fremgangsmaate for fremstilling og anvendelse av substituerte 2',3'-didesoksy-5-trifluormetyluridiner
NO903347D0 (no) Fremgangsmaate for fremstilling av 14,17alfa-ethano- og ethanooestratriener.
NO891985D0 (no) Fremgangsmaate for fremstilling av dibenzotiofen- og tioxanten-derivater.
NO920938D0 (no) Fremgangsmaate til fremstilling av oksamid
NO920636D0 (no) Fremgangsmaate for fremstilling av 9-amino-1,2,3,4-tetra-hydroakridin
NO905543L (no) Fremgangsmaate for fremstilling og anvendelse av aminopyridinylmetanoler og aminometylpyridinaminer.
IT1252659B (it) Procedimento per la depurazione dell'1,1,1-trifluoro-2-fluoroetano e dell'1,1,1-trifluoro-2,2-dicloroetano
NO933262L (no) Fremgangsmaate for fremstilling av alkosymagnesiumhalogenider
ITMI931371A1 (it) Procedimento per la preparazione dell'erdosteina
NO912279L (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO921363L (no) Fremgangsmaate til fremstilling av 4'-demetylepipodofyllotoksin-glukosid-4'-fosfater
KR930703291A (ko) 치환된 피리딜피리미딘, 그의 제조방법 및 용도, 및 신규한 중간체
NO914654L (no) Fremgangsmaate for fremstilling og anvendelse av beta-hydroksyetylaminer med 1,1-disubstituert cyklopropylrest